Evidence map›Paper›PMID 36652499›Full record

ArticlePLoS genetics2023

G protein-coupled receptor kinase-2 (GRK-2) controls exploration through neuropeptide signaling in Caenorhabditis elegans.

Kristen Davis, Christo Mitchell, Olivia Weissenfels, Jihong Bai, David M Raizen, Michael Ailion, Irini Topalidou

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Kristen DavisDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Christo MitchellDepartment of Biochemistry, University of Washington, Seattle, Washington, United States of America.
Olivia WeissenfelsDepartment of Biochemistry, University of Washington, Seattle, Washington, United States of America.
Jihong BaiFred Hutchinson Cancer Center, Seattle, Washington, United States of America.
David M RaizenDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Michael AilionDepartment of Biochemistry, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0002-8070-1362
Irini TopalidouDepartment of Biochemistry, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0003-1115-4251
University of Washington · USFred Hutch Cancer Center · USThomas Jefferson University · USUniversity of Pennsylvania · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI A. Clementina Mesaros · 2006 to 2026
$35.3M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Translational Research Training Program in Environmental Health SciencesT32ES019851 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Kara A Bernstein, Trevor M Penning · 2012 to 2026
$6.0M
Mechanism of Sleep Regulation by SIK3R01NS107969 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI David Menassah Raizen, Alexander M Van der Linden · 2019 to 2026
$2.9M
Signaling Pathways that Modulate Neuronal ActivityR01NS109476 · NINDS · UNIVERSITY OF WASHINGTON · PI Michael Ailion, Jihong Bai · 2020 to 2026
$2.5M
Mechanistic studies of sickness sleepR01NS122779 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI RAIZEN, DAVID MENASSAH · 2021 to 2025
$2.0M
Proteins important for dense-core vesicle functionR01GM121481 · NIGMS · UNIVERSITY OF WASHINGTON · PI AILION, MICHAEL · 2018 to 2022
$1.8M
NIEHS NIH HHS P30 ES013508NIEHS NIH HHS T32 ES019851NIGMS NIH HHS R01 GM121481NIH HHS P40 OD010440NINDS NIH HHS R01 NS107969NINDS NIH HHS R01 NS109476NINDS NIH HHS R01 NS122779
6 · The paper itself

Abstract

Animals alter their behavior in manners that depend on environmental conditions as well as their developmental and metabolic states. For example, C. elegans is quiescent during larval molts or during conditions of satiety. By contrast, worms enter an exploration state when removed from food. Sensory perception influences movement quiescence (defined as a lack of body movement), as well as the expression of additional locomotor states in C. elegans that are associated with increased or reduced locomotion activity, such as roaming (exploration behavior) and dwelling (local search). Here we find that movement quiescence is enhanced, and exploration behavior is reduced in G protein-coupled receptor kinase grk-2 mutant animals. grk-2 was previously shown to act in chemosensation, locomotion, and egg-laying behaviors. Using neuron-specific rescuing experiments, we show that GRK-2 acts in multiple ciliated chemosensory neurons to control exploration behavior. grk-2 acts in opposite ways from the cGMP-dependent protein kinase gene egl-4 to control movement quiescence and exploration behavior. Analysis of mutants with defects in ciliated sensory neurons indicates that grk-2 and the cilium-structure mutants act in the same pathway to control exploration behavior. We find that GRK-2 controls exploration behavior in an opposite manner from the neuropeptide receptor NPR-1 and the neuropeptides FLP-1 and FLP-18. Finally, we show that secretion of the FLP-1 neuropeptide is negatively regulated by GRK-2 and that overexpression of FLP-1 reduces exploration behavior. These results define neurons and molecular pathways that modulate movement quiescence and exploration behavior.

Indexed as

Caenorhabditis elegans ProteinsNeuropeptidesAnimalsCaenorhabditis elegansCyclic GMP-Dependent Protein KinasesLocomotionReceptors, G-Protein-CoupledSensory Receptor CellsCaenorhabditis elegans ProteinsCyclic GMP-Dependent Protein KinasesEGL-4 protein, C elegansFlp-1 protein, C elegansNeuropeptidesReceptors, G-Protein-Coupled

Identifiers

PMID36652499
PMCPMC9886303
OpenAlexW4317242690

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.